Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00234728 · ClinicalTrials.gov registry record · NA

Study of a New Dressing for Use With Topical Medications

A NA study, sponsored by Teikoku Pharma USA.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT00234728 is a NA study that has completed, run by Teikoku Pharma USA. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00234728, a NA study, has completed, sponsored by Teikoku Pharma USA.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.

Interventions

  • DEVICE Occlusive dressing

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2005-09
Est. Completion 2007-06
Phase NA

Sponsor

Teikoku Pharma USA

5 total trials

What the Registry Record Tells You About NCT00234728

The ClinicalTrials.gov registry entry for NCT00234728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teikoku Pharma USA, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Occlusive dressing is the first listed.

NCT00234728 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00234728 about?

NCT00234728 is a clinical study titled "Study of a New Dressing for Use With Topical Medications". The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.

What is the current status of trial NCT00234728?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2005-09. Estimated completion is 2007-06.

What interventions are being tested in trial NCT00234728?

The interventions under investigation include: Occlusive dressing (DEVICE).

Who is sponsoring clinical trial NCT00234728?

This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.